摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,2-环己二硫醇 | 61947-27-1

中文名称
1,2-环己二硫醇
中文别名
——
英文名称
1,2-cyclohexanedithiol
英文别名
Cyclohexane-1,2-dithiol
1,2-环己二硫醇化学式
CAS
61947-27-1
化学式
C6H12S2
mdl
——
分子量
148.293
InChiKey
YKRCKUBKOIVILO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    98-100 °C(Press: 15 Torr)
  • 密度:
    1.06±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    8
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    2
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:b92c3ec26bea2f756b36634a27c48f98
查看

反应信息

  • 作为反应物:
    描述:
    1,2-环己二硫醇3-氯-2-丁酮 以to give 4a,5,6,7,8,8a-hexahydro-2,3-dimethyl-1,4-benzodithiin as a colorless oil, bp 100°-102°/0.2 mm的产率得到4a,5,6,7,8,8a-hexahydro-2,3-dimethyl-1,4-benzodithiin
    参考文献:
    名称:
    Substituted dithiin tetroxide plant growth regulants
    摘要:
    植物生长的调节,包括除草剂、落叶剂或干燥剂效应,可以通过某些2,3-二氢-1,4-二硫杂环己烷-1,1,4,4-四氧化物来实现,其化学式为##STR1##其中R的值可以是氢、烷基等不同的取值。其中某些化合物,如2,3-二氢-5,6-二甲基-1,4-二硫杂环己烷-1,1,4,4-四氧化物是新的化学物质,可用作前和后出苗除草剂,并用于收获辅助程序,如对棉花和土豆等不同作物的落叶/干燥。
    公开号:
    US04276422A1
点击查看最新优质反应信息

文献信息

  • New amino-dithiaphospholanes and phosphoramidodithioites and their rhodium and iridium complexes
    作者:Pushkar Shejwalkar、Sergey L. Sedinkin、Eike B. Bauer
    DOI:10.1016/j.ica.2010.11.006
    日期:2011.1
    on the spectroscopic properties of their rhodium and iridium complexes was investigated. The new ligands Bn 2 NPSCH 2 CH 2 S a ( P - S a ) (Bn = benzyl, 4 ), Bn 2 NPSCHCHS a (CH 2 ) 3 C a H 2 ( P - S a )( C a - S a ) ( 6 ) and Bn 2 NP(4-XC 6 H 4 OMe) 2 (X = S, 7a ; X = O, 7b ) were converted to the rhodium and iridium complexes trans -[Rh(CO)Cl(L) 2 ] (L = 4 , 6 , 7 ), [RhCl(COD)(L)] (L = 4 , 6 , 7
    摘要合成了亚磷酰胺配体的新硫衍生物,研究了硫单元对其铑和铱配合物光谱性质的影响。新的配体Bn 2 NPSCH 2 CH 2 S a(P-SA)(Bn =苄基,4),Bn 2 NPSCHCHS a(CH 2)3 C a H 2(P-SA)(C a-S a )(6)和Bn 2 NP(4-XC 6 H 4 OMe)2(X = S,7a; X = O,7b)转化为铑和铱配合物反式-[Rh(CO)Cl(L) 2](L = 4,6,7),[RhCl(COD)(L)](L = 4,6,7),[IrCl(COD)(7a)]和[IrCl 2 Cp ∗(6)] 。为了比较,还合成了这些制剂的一些亚磷酰胺配合物。光谱分析了新的金属配合物。对于羰基配合物,其v CO IR拉伸频率低于相应的亚磷酸酯和亚磷酰胺配体。具有新配体的铑配合物的1 J PRh耦合常数也小于相应的亚磷酰胺和亚磷酸盐配合物的1 J PRh耦合常数。最后,新配体的硒化物的1
  • [EN] COSMETIC PROCESS FOR ATTENUATING WRINKLES<br/>[FR] PROCÉDÉ COSMÉTIQUE POUR ATTÉNUER LES RIDES
    申请人:OREAL
    公开号:WO2016050788A1
    公开(公告)日:2016-04-07
    The invention relates to a cosmetic process for wrinkled skin, comprising either the topical application to the skin of an extemporaneous mixture of a cosmetic composition comprising a polysaccharide polymer grafted with (meth)acrylate groups and of a crosslinking thiol compound having one or more thiol groups; or the sequential application to the skin of a cosmetic composition comprising a polysaccharide polymer grafted with (meth)acrylate groups, followed by the application of a crosslinking thiol compound having one or more thiol groups, or of a cosmetic composition containing same. The invention also relates to the use of the mixture of said grafted polysaccharide polymer and of said crosslinking thiol as a skin tensioning agent. The invention also relates to a cosmetic composition obtained by mixing a cosmetic composition comprising said grafted polysaccharide polymer and said crosslinking thiol. The invention relates to a kit comprising a first cosmetic composition comprising said grafted polysaccharide polymer and a second composition comprising said crosslinking thiol, the first and second compositions each been packaged in a distinct packaging assembly.
    该发明涉及一种用于皱纹皮肤的化妆过程,包括以下两种方式:要么将一种化妆组合物涂抹在皮肤上,该组合物包括一种聚糖聚合物,其与(甲基)丙烯酸酯基团进行嫁接,以及一种具有一个或多个硫醇基团的交联硫醇化合物的现场混合物;要么将一种包括聚糖聚合物,其与(甲基)丙烯酸酯基团进行嫁接的化妆组合物顺序涂抹在皮肤上,然后涂抹一种具有一个或多个硫醇基团的交联硫醇化合物,或者含有该化合物的化妆组合物。该发明还涉及将所述嫁接聚糖聚合物和所述交联硫醇的混合物用作皮肤紧致剂。该发明还涉及通过混合包括所述嫁接聚糖聚合物和所述交联硫醇的化妆组合物而获得的化妆组合物。该发明涉及一种套装,包括第一化妆组合物,其中包括所述嫁接聚糖聚合物,以及第二组成物,其中包括所述交联硫醇,第一和第二组成物分别被包装在不同的包装组件中。
  • [EN] CONTROLLED-RELEASE CNP AGONISTS WITH INCREASED NEP STABILITY<br/>[FR] AGONISTES CNP À LIBÉRATION CONTRÔLÉE PRÉSENTANT UNE MEILLEURE STABILITÉ À NEP
    申请人:ASCENDIS PHARMA GROWTH DISORDERS AS
    公开号:WO2017118700A1
    公开(公告)日:2017-07-13
    The present invention relates to controlled-release CNP agonists having an at least 5-fold longer degradation half-life in an in vitro NEP degradation assay than the corresponding released CNP agonist, to pharmaceutical compositions comprising said controlled-release CNP agonist, their use and to methods of treatment.
    本发明涉及具有至少5倍长的降解半衰期的控制释放的CNP激动剂,在体外NEP降解测定中比相应释放的CNP激动剂,以及包含所述控制释放的CNP激动剂的药物组合物,它们的用途和治疗方法。
  • CATALYST FOR STEREOSELECTIVE OLEFIN POLYMERIZATION AND METHOD FOR MANUFACTURING STEREOSELECTIVE POLYOLEFIN
    申请人:Ishii Akihiko
    公开号:US20130059991A1
    公开(公告)日:2013-03-07
    A stereoselective olefin polymerization catalyst contains a complex represented by Formula (1): wherein n is 2 or 3; R 1 and R 2 are independently an optionally substituted alkyl group or a halogen atom; L is a ligand represented by CH 2 R 3 , a halogen atom, OR 4 , or NR 5 R 6 ; R 3 is a hydrogen atom, an aromatic group, or a trialkylsilyl group; R 4 is a lower alkyl group having 1 to 6 carbon atoms; and R 5 and R 6 are independently a hydrogen atom or a lower alkyl group having 1 to 6 carbon atoms. A method for manufacturing stereoselective polyolefin, includes polymerizing an olefin in the presence of the catalyst. The present invention provides a catalyst which enables highly isoselective polymerization generating a polymer having significantly high molecular weight and also can prepare stereoselective polyolefin with a narrow dispersity (Mw/Mn) or with a sharp molecular weight distribution, and provides a method for manufacturing stereoselective polyolefin with the catalyst.
    一种立体选择性烯烃聚合催化剂包含由式(1)表示的复合物: 其中n为2或3;R1和R2分别为可选择取代的烷基或卤素原子;L为CH2R3表示的配体、卤素原子、OR4或NR5R6;R3为氢原子、芳香族基团或三烷基硅基团;R4为具有1至6个碳原子的低烷基基团;R5和R6分别为氢原子或具有1至6个碳原子的低烷基基团。一种制备立体选择性聚烯烃的方法包括在催化剂存在下聚合烯烃。本发明提供了一种催化剂,可以实现高度立体选择性的聚合,生成具有显著高分子量的聚合物,并且可以制备具有窄分子量分布(Mw/Mn)或尖锐分子量分布的立体选择性聚烯烃,并提供了一种使用该催化剂制备立体选择性聚烯烃的方法。
  • Internal release agent, composition including internal release agent, and process for producing a plastic lens using same composition
    申请人:MITSUI CHEMICALS, INC.
    公开号:US10239239B2
    公开(公告)日:2019-03-26
    An internal release agent includes at least one phosphodiester represented by the following general formula (1). In the formula, R1 and R2 independently represent a hydrocarbon group having 1 to 30 carbon atoms, which is optionally substituted with at least one hydroxyl group, and R3 represents an alkylene group having 2 to 4 carbon atoms. A plurality of R3's may be the same as or different from each other. M represents a hydrogen atom, an ammonium ion, an alkali metal ion, or a monovalent/divalent alkali earth metal ion, and n is an integer of 1 to 60.
    内部释放剂至少包括一个由以下一般式(1)表示的磷酸二酯。在该式中,R1和R2分别表示具有1至30个碳原子的烃基,该烃基可以选择性地取代至少一个羟基,而R3表示具有2至4个碳原子的烷基基团。多个R3可以相同或者彼此不同。M代表氢原子、铵离子、碱金属离子或者一价/二价碱土金属离子,n为1至60的整数。
查看更多